Comparison of haemocompatibility improvement of four polymeric biomaterials by two heparinization techniques

Biomaterials

Volumn 24, Issue 4, 2003, Pages 677-688

  Michanetzis, G P A ^a   Katsala, N ^a   Missirlis, Y F ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Atomic force microscopy; Covalent binding; Haemocompatibility; Heparinization; Scanning electron microscopy

Indexed keywords

BIOCOMPATIBILITY; MORPHOLOGY; POLYETHYLENES; POLYPROPYLENES; POLYVINYL CHLORIDES; RUBBER; SCANNING ELECTRON MICROSCOPY; SILICONES;

HERAPINIZATION;

BIOMATERIALS;

HEMOGLOBIN; POLYETHYLENE; POLYMER; POLYPROPYLENE; POLYVINYLCHLORIDE; SILASTIC;

ARTICLE; BIOCOMPATIBILITY; BLOOD CLOTTING; HEPARINIZATION; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; THROMBOCYTE;

BLOOD COAGULATION; BLOOD PLATELETS; COATED MATERIALS, BIOCOMPATIBLE; HEPARIN; HUMANS; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; PLATELET ACTIVATION; PLATELET ADHESIVENESS; POLYMERS;

EID: 0037290232     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0142-9612(02)00382-4     Document Type: Article

References (65)

1. Pusineri C., Cazenave J.P. Techniques for modifying artificial surfaces. Cazenave J.P., Davies J., Kazatchkine M.D., van Aken W.G. Blood-surface interactions: biological principles underlying haemocompatibility with artificial materials. 1986;209-235 Elsevier Science Publishers, Amsterdam.
2. Hoffman A.S. Modification of material surfaces to affect how they interact with blood. Ann NY Acad Sci. 516:1987;96-101.
3. Kim S.W., Feijen S. Surface modification of polymers for improved blood compatibility. Williams D.F. CRC critical reviews in biocompatibility VI I3. 1985;229-260 CRC Press, Boca Raton, FL.
4. Van Delden C.J., Lens J.P., Kooyman R.P.H., Engbers G.H.M., Feijen J. Heparinization of gas-plasma modified polystyrene surfaces and the interaction of these surfaces with proteins studied with surface plasmon resonance. Biomaterials. 12:1997;845-852.
5. Ratner B.D. Surface modification of polymeric biomedical applications. chemical, biological, and surface analytical challenges Ratner B.D., Castner D.G. Surface modification of polymeric biomaterials. 1997;1-9 Plenum Press, New York, NY.
6. Sheu M.S., Hoffman A.S., Ratner B.D., Feijen J., Harris J.M. Immobilization of polyethylene oxide surfactants for non-fouling biomaterial surfaces using an argon glow discharge treatment. J Adhes Sci Technol. 7(10):1993;1065-1076.
7. Ratner B.D. Biomaterials science. overview and opportunities with special reference to organic and polymeric glow discharge plasma treatments D'Agostino R. Plasma treatments and depositions of polymers. 1997;453-464 Kluwer Academic Publishers, Dordrecht.
8. Ratner B.D. Surface modification of polymers. chemical, biological and surface analytical challenges Biosensors Bioelectron. 10:1995;797-804.
9. Ratner BD, Castner DG, editors. Surface Modification of Polymeric Biomaterials. New York, NY: Plenum Press, 1997. p. 206.
10. Hoffman J., Larm O., Scholander E. A new method for covalent coupling of heparin and other glycosaminoglycans to substances containing primary amino groups. Carbohydr Res. 117:1983;328-331.
11. Brynda E., Houska M., Jirouskova M., Dyr J.E. Albumin and heparin multilayer coatings for blood-contacting material devices. J Biomed Mater Res. 2:2000;249-257.
12. Van Delden C.J., Engbers G.H.M., Feijen J. Interaction of ATIII with surface immobilized albumin heparin conjugates. J Biomed Mater Res. 29:1995;1317-1329.
13. Jacobs H., Grainger D., Okano T., Kim S.W. Surface modification for improved blood compatibility. Artif Organs. 6:1988;506-507.
14. Cremers H.F.M., Kwon G., Bae Y.H., Kim S.W., Verrijh R., Noteborn H.P.J.M., Feijen J. Preparation and characterization of albumin-heparin microspheres. Biomaterials. 1:1994;38-48.
15. Hennink W.E., Kim S.W., Feijen J. Inhibition of surface induced coagulation by preadsorption of albumin-heparin conjugates. J Biomed Mater Res. 18:1984;911-926.
16. Brazel C.S., Peppas N.A. Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels. J Contr Rel. V39 I1:1996;57-64.
17. Hinrichs W.L.J., ten Hoopen H.W.M., Wissink M.J.B., Engbers G.H.M., Feijen J. Desighn of a new type of coating for the controlled release of heparin. J Contr Rel. V45 I2:1997;163-176.
18. Kreitz M.R., Domm J.A., Mathiowitz E. Controlled delivery of therapeutics from microporous membranes. II. In vitro defradation and release of heparin-loaded poly(D,L-lactide-co-glycolactide). Biomaterials. 24:1997;1645-1651.
19. Kim Y.J., Kang I-.K., Huh M.W., Yoon S-.C. Surface characterization and in vitro blood compatibility of poly(ethylene teraphthalate) immobilized with insulin and/or heparin using plasma glow discharge. Biomaterials. 2:2000;121-130.
20. Gott V.L., Whiffen J.D., Dutton R.C. Heparin bonding on colloidal graphite surfaces. Science. 142:1963;1297-1298.
21. Wilson J.E. Heparinised polymers as thromboresistant biomaterials. Polym Plast Technol Eng. 16(2):1981;119-208.
22. Lane DA, Undahl U, editors. Heparin. Boca Raton, FL: CRC Press, 1989.
23. Lemm W, editor. The Reference Materials of the European Communities: Results of Hemocompatibility Tests. Dordrecht: Kluwer Academic Publishers, 1992.
24. Bamford C.H., AI-Lamee K.G. Studies in polymer surface modification and grafting for biomedical uses. Polymer. 22:1996;4885-4889.
25. Bamford C.H., Al-Lamee K.G. Studies in polymer surface functionalization and grafting for biomedical and other applications. Polymer. 13:1994;2844-2852.
26. Seifert B., Groth T. Immobilization of heparin on polylactide for application to degradable biomaterials in contact with blood. J Biomater Sci Polym Ed. 7(3):1995;277-287.
27. Mino G., Kaizerman S. The new method for the preparation of graft copolymers. Polymerization initiated by ceric ion redox systems. J Polym Sci. 31(122):1958;242-243.
28. Peppas N.A., Merill E.W. Development of semicrystalline PVA networks for biomedical applications. J Biomed Mater Res. 11:1977;423-434.
29. Farndale R.W., Buttle D.J., Barret A.J. Improved quantitation and discrimination of sulphate glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta. 883:1986;173-177.
30. Van de Lest C.H., Versteeg E.M., Veerkamp J.H., van Kuppevelt T.H. A spectrophotometric method for the determination of heparan sulfate. Biochim Biophys Acta. 1201:1994;305-311.
31. Lemm W. Test for dynamic stress and strain. Dawids S. Test procedures for the blood compatibility of biomaterials. 1993;59-62 Kluwer Academic Publishers, Dordrecht.
32. Cazenave J.P., Mulvihill J.N. Methods to study blood-surface interactions. Missirlis Y.F., Lemm W. Modern aspects of protein adsorption on biomaterials. 1991;49-53 Kluwer Academic Publishers, Dordrecht.
33. Missirlis Y.F., Michanetzis G.P.A. Measurement of platelet adhesion, released βTG and generated FPA using whole non-anticoagulated blood at flow conditions. Lemm W. The reference materials of the European communities. 1992;157-164 Kluwer Academic Publishers, Dordrecht.
34. Rhodes N.P., Williams D.F. Plasma recalcification as a measure of contact phase activation and heparinization efficacy after contact with biomaterials. Biomaterials. 1:1994;35-37.
35. West R.H., Paul A.J., Hibbert S., Cahalan P., Cahalan L., Verhoeven M., Hendriks M., Fouache B. Correlation of the surface chemistries of polymer bioactive coatings with their biological performances. J Mater Sci: Mater Med. 6:1995;63-67.
36. Baumann H., Keller R. Which glycosaminoglycans are suitable for antithrombogenic or athrombogenic coatings of biomaterials? Part II. Covalently immobilized endothelial cell surface heparan sulfate (ESHS) and heparin (HE) on synthetic polymers and results of animal experiments. Semin Thromb Hemost. V23 I2:1997;215-223.
37. Ferruti P., Barbucci R., Barozzi C., Casini G., Tempesti F. Heparin adsorbing resins of poly(amido-amine) structure and surface structure of poly(amido-amines) on various materials. Dawids S., Bantjes A. Blood compatible materials and their testing. 1986;187-192 Martinus Nijhoff Publishers, Dordrecht.
38. Garred P., Mollnes T.E. Immobilized heparin inhibits the increase in leukocyte surface expression of adhesion molecules. Artif Organs. 4:1997;293-299.
39. Marconi F., Benvenuti F., Piozzi A. Covalent bonding of heparin to a vinyl copolymer for biomedical applications. Biomaterials. 12:1997;885-890.
40. Lindhout T., Blezer R., Schoen P., Willems G.M., Fouache B., Verhoefen M., Hendriks M., Cahalan L., Cahalan P.T. Antithrombin activity of surface-bound heparin studied under flow conditions. J Biomed Mater Res. V29 I10:1995;1255-1266.
41. Sailynoja E., Koskinen M., Salonen J., Holmlund P., Sodergard A., Koskinen M. Immobilization of a biologically active coating on a hydrophobic L-lactide-ε-caprolactone copolymer. J Mater Sci: Mater Med. 12:1999;703-705.
42. Seifert P., Romaniuk P., Groth Th. Bioresorbable, heparinized polymers for stent coating. in vitro studies on heparinization efficiency, maintenance of anticoagulant properties and improvement of stent haemocompatibility J Mater Sci: Mater Med. 7:1996;465-469.
43. Salzman E.W. Measurement of platelet adhesiveness. a simple in vitro technique demonstrating an abnormality in von Willebrand disease J Lab Clin Med. 62:1963;274.
44. Kulik E, Blezer R, Verhoeven M, Gillissen M, Cahalan P, Hendriks M. Simple method of heparin immobilization on lubricious surface. Proceedings of the Sixth World Biomaterials Congress Transactions, Hawaii, USA, 2000, p. 521.
45. Levy M., Hartman A.R. Heparin-coated bypass circuits in cardiopulmonary bypass. improved biocompatibility or not Int J Cardiol. V53 S1:1996;S81-S87.
46. Ito Y. Micropattern immobilization of polysaccharide. J Inorg Biochem. 79:2000;77-81.
47. Keldenich S., Kopp R., Kirshfink M., Klein B., Henseler A., Thelen H., Oedekoven B., Mottaghy K. Application of a new dynamic flow model for investigating the biocompatibility of modified surfaces. ASAIO J. V46 I1:2000;134-141.
48. Bannan S., Danby A., Cowan D., Ashraf S., Gesinde M., Martin P. Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in virto model. Eur J Cardiothoracic Surg. V12 I2:1997;268-275.
49. Mollnes T.E., Videm V., Christiansen D., Bergseth G., Riesenfeld J., Hovig T. Platelet compatibility of an artifificial surface modified with functionally active heparin. Thromb Haemost. 82:1999;1132-1136.
50. Nojiri C., Park K.D., Grainger D.W., Jacobs H.A., Okano T., Koyanji H., Kim S.W. In vivo non thrombogenicity of heparin immobilized polymer surfaces. ASAIO Trans. 36(3):1990;M168-172.
51. Nojiri C., Kido T., Sugiyama T., Horiuchi K., Kijima T., Hagiwara K., Kuribayashi E., Nogawa A., Ogiwara K., Akutsu T. Can heparin immobilized surfaces maintain nonthrombogenic activity during in vivo long-term implantation? ASAIO J. V24 I5:1996;M468-M475.
52. Borowiec J., Bagge L., Saldeen T., Thelin S. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits. Thoracic Cardiovasc Surg. V45 I4:1997;163-167.
53. Plate N.A., Valuev L.T. On the mechanism of the enhanced thromboresistance of polymeric materials in presence of heparin. Biomaterials. 4:1983;14-20.
54. Sanchez J., Elgue G., Riesenfeld J., Olsson P. Control of contact activation on end-point immobilized heparin. the role of antithrombin and the specific antithrombin-binding sequence J Biomed Mater Res. 37(1):1997;37-42.
55. Rosenberg R.D., Bauer K.A. The heparin-antithrombin system. a natural anticoagulant mechanism Colman R.W., Hirsh J., Marder V.J., Salzman E.W. Hemostasis and thrombosis: basic principles and clinical practice. 3rd ed:1994;837-860 JB Lippincott Co. Philadelphia, PA.
56. Wendel H.P., Ziemer G. Coating-techniques to improve the hemocompatibility of atrificial devices used for extracorporeal circulation. review article Eur J Cardiothoracic Surg. 16:1999;342-350.
57. Wendel H.P., Weber N., Ziemer G. Increased adsorption of high molecular weight kininogen to heparin-coated artificial surfaces and correlation to hemocompatibility. Immunopharmacology. 43:1999;149-153.
58. Yu J.L., Johansson S., Ljungh O. Fibronectin exposes different domains after adsorption to a heparinized poly(vinyl chloride) surface. Biomaterials. 5:1997;421-427.
59. Magnani A., Busi E., Barbucci R. In situ ATR/FTIR studies of protein adsorption on polymeric materials. effectiveness of surface heparinization J Mater Sci: Mater Med. V5 I12:1994;839-843.
60. Magnani A., Barbucci R. Conformation of human plasma proteins at polymer surfaces. the effectiveness of surface heparinization Biomaterials. 12:1994;955-962.
61. Maillet F., Pepitou M., Choay J., Kazatchkine M.D. Structure-function relationships in the inhibitory effect of heparin on the complement activation. indipendency of the anti-coagulant and anti-complementary sites on the heparin molecule Mol Immunol. 25:1988;917-923.
62. Zhou D., Too C.O., Wallace G.G. Synthesis and characterization of polypyrrole/heparin composites. React Funct Polym. 39:1999;19-26.
63. Garner B., Hodson A.J., Wallace G.G., Underwood P.A. Human endothelial cell attachment to and growth on polypyrrole-heparin is vitronectin dependent. J Mat Sci: Mater Med. 10:1999;19-27.
64. Da Luz Moreira P., Furlan Wada M.L., Novello W.P. Importance of uniform heparin coating on biopolymes. Artif Organs. 3:2000;209-211.
65. Li H., Rief M., Oesterhelt F., Gaub H.E., Zhang X., Shen J. Single molecule force spectroscopy on polysaccharides by AFM-nanomechanical fingerprint of α-(1,4)-linked polysaccharides. Chem Phys Lett. 305:1999;197-201.